Abstract Presentation Highlights From the 2023 AAAAI Annual Meeting

Authors

  • Susan Waserman, MSc, MDCM, FRCPC Division of Clinical Immunology and Allergy, McMaster University
  • Jason Ohayon, MD, FRCPC McMaster University
  • Paul Keith, MD Division of Clinical Immunology and Allergy, McMaster University

DOI:

https://doi.org/10.58931/cait.2023.3140

Abstract

Many oral abstracts, posters and case reports were presented at the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting which was held in February 2023 in San Antonio, Texas. We have selected the following seven articles due to their relevance to Canadian allergy and immunology clinical practice and research. 

Author Biographies

Susan Waserman, MSc, MDCM, FRCPC, Division of Clinical Immunology and Allergy, McMaster University

Dr. Susan Waserman is a Professor of Medicine, Director of the Division of Clinical Immunology and Allergy at McMaster University and the Adverse Reactions Clinic at the Firestone Institute of Respiratory Health, St. Joseph’s Healthcare.

Jason Ohayon, MD, FRCPC, McMaster University

Dr. Jason Ohayon is a consultant allergist and immunologist in Hamilton, ON, an Assistant Clinical Professor at McMaster University, the research director at HamiltonAllergy.ca and the co-founder of iCASE Allergy Associates.

Paul Keith, MD, Division of Clinical Immunology and Allergy, McMaster University

Dr. Paul Keith is a Professor of Medicine and Director of the Division of Clinical Immunology and Allergy at McMaster University.

References

Greenhawt M, et al. Comparison of the pharmacokinetic and pharmacodynamic profiles of epinephrine delivered by a sublingually absorbed film (DESF), versus 0.3 mg administered by a standard IM injection or the EpiPen. J Allergy Clin Immunol. 2023 Feb;151(2):AB4.

Lieberman J, et al. Epinephrine intranasal Spray 2.0 mg Versus Epinephrine Injection Products: An Integrated Pharmacokinetic Analysis. J Allergy Clin Immunol. 2023 Feb;151(2):AB5.

Sillcox C, et al. Assessing allergic reactions to cephalosporins in children. J Allergy Clin Immunol. 2023 Feb;151(2):AB113.

Ramsay A, Mustafa SS. A Randomized Trial of Penicillin Skin Testing Versus 2-Step Direct Challenge for Penicillin Allergy During Pregnancy. J Allergy Clin Immunol. 2023 Feb;151(2):AB207.

Patel G, Crain M, Bird JA, et al. Intravenous Access Is Rarely Necessary For FPIES Oral Food Challenges. J Allergy Clin Immunol. 2023 Feb;151(2):AB215.

Nathan M. Possible pollen induced anaphylaxis during elevated pollen levels in the environment in a cohort of idiopathic anaphylactic children. J Allergy Clin Immunol. 2023 Feb;151(2):AB3.

Abstract Presentation Highlights From the 2023 AAAAI Annual Meeting

Downloads

Published

2023-05-01

How to Cite

1.
Waserman S, Ohayon J, Keith P. Abstract Presentation Highlights From the 2023 AAAAI Annual Meeting. Can Allergy Immunol Today [Internet]. 2023 May 1 [cited 2024 Oct. 10];3(1):12–17. Available from: https://canadianallergyandimmunologytoday.com/article/view/3-1-waserman_et_al

Issue

Volume 3, Issue 1, May 2023

Section

Articles